Derek O'HaganHead of Global Discovery Support & New Technologie at GSK Vaccines
I am currently a Senior Advisor in Technical R&D in GSK Vaccines, since 2018, and also a GSK Fellow, since 2019. Prior to this I was the Global Head of Discovery Support and New Technology in GSK Vaccines. Until 2015, I was the Global Head of Vaccine Chemistry and Formulation Research for Novartis Vaccines. I was part of the original Team that established the program on Self Amplifying RNA vaccines (SAM) in Novartis, Cambridge, which is now an active program in GSK. I served on the Board of Scientific Advisors for the Controlled Release Society and I am a Fellow of the American Association of Pharmaceutical Scientists.